senate Bill S3543

2019-2020 Legislative Session

Relates to the definition of over the counter contraceptive products and voluntary sterilization procedures

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (7)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Mar 14, 2019 referred to insurance
delivered to assembly
passed senate
Mar 13, 2019 advanced to third reading
Mar 12, 2019 2nd report cal.
Mar 11, 2019 1st report cal.245
Feb 08, 2019 referred to women's issues

Votes

view votes

Mar 11, 2019 - Women's Issues committee Vote

S3543
6
0
committee
6
Aye
0
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Women's Issues committee vote details

Women's Issues Committee Vote: Mar 11, 2019

S3543 (ACTIVE) - Details

Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3221, 4303 & 3216, Ins L (as proposed in S.659-A and A.585-A)

S3543 (ACTIVE) - Summary

Relates to the definition of over the counter contraceptive products and voluntary sterilization procedures.

S3543 (ACTIVE) - Sponsor Memo

S3543 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  3543

                       2019-2020 Regular Sessions

                            I N  S E N A T E

                            February 8, 2019
                               ___________

Introduced  by  Sen. SALAZAR -- read twice and ordered printed, and when
  printed to be committed to the Committee on Women's Issues

AN ACT to amend the insurance law, in relation to the definition of over
  the counter contraceptive products and voluntary sterilization  proce-
  dures

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Subparagraph (A) of  paragraph  16  of  subsection  (l)  of
section  3221  of the insurance law, as amended by a chapter of the laws
of 2019 amending the insurance law and the social services law, relating
to requiring health  insurance  policies  to  include  coverage  of  all
FDA-approved  contraceptive  drugs,  devices,  and  products, as well as
voluntary sterilization procedures, contraceptive  education  and  coun-
seling,  and  related follow up services and prohibiting a health insur-
ance  policy  from  imposing  any  cost-sharing  requirements  or  other
restrictions  or  delays  with  respect to this coverage, as proposed in
legislative bills numbers S. 659-A and A. 585-A, is amended  and  a  new
subparagraph (H) is added to read as follows:
  (A)  Every  group  or  blanket  policy  THAT  PROVIDES  MEDICAL, MAJOR
MEDICAL, OR SIMILAR COMPREHENSIVE-TYPE COVERAGE that is issued, amended,
renewed, effective or delivered on or after January first, two  thousand
twenty,  shall  provide  coverage  for all of the following services and
contraceptive methods:
  (1) All FDA-approved contraceptive drugs, devices, and other products.
This includes all  FDA-approved  over-the-counter  contraceptive  drugs,
devices,  and  products  as  prescribed or as otherwise authorized under
state or federal law. The following applies to this coverage:
  (a) where the FDA has approved one or more therapeutic and  pharmaceu-
tical  equivalent,  as  defined  by the FDA, versions of a contraceptive
drug, device, or product, a group or blanket policy is not  required  to
include  all  such therapeutic and pharmaceutical equivalent versions in

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.